A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

NCT03649971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenomatous Polyposis Coli

Interventions

DRUG: Guselkumab
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC